These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4061688)

  • 21. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced cortisol latency in depressive illness.
    Jarrett DB; Coble PA; Kupfer DJ
    Arch Gen Psychiatry; 1983 May; 40(5):506-11. PubMed ID: 6838331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline cortisol measures and developmental pathways of anxiety in early adolescence.
    Greaves-Lord K; Huizink AC; Oldehinkel AJ; Ormel J; Verhulst FC; Ferdinand RF
    Acta Psychiatr Scand; 2009 Sep; 120(3):178-86. PubMed ID: 19485962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of the adrenal cortex in patients with major depression.
    Kalin NH; Dawson G; Tariot P; Shelton S; Barksdale C; Weiler S; Thienemann M
    Psychiatry Res; 1987 Oct; 22(2):117-25. PubMed ID: 2825229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder.
    Casper RC; Swann AC; Stokes PE; Chang S; Katz MM; Garver D
    Acta Psychiatr Scand; 1987 Mar; 75(3):243-50. PubMed ID: 3473911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
    Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
    Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.
    Maes M; Minner B; Suy E; Vandervorst C; Raus J
    J Neural Transm Gen Sect; 1991; 85(3):195-210. PubMed ID: 1930881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The central mechanism of hypothalamic-pituitary-adrenocortical system hyperfunction in depressed patients.
    Jiang HK; Wang JY; Lin JC
    Psychiatry Clin Neurosci; 2000 Apr; 54(2):227-34. PubMed ID: 10803820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
    Pivac N; Jakovljević M; Mück-Seler D; Brzović Z
    Psychiatry Res; 1997 Dec; 73(3):123-32. PubMed ID: 9481804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
    Swann AC; Stokes PE; Casper R; Secunda SK; Bowden CL; Berman N; Katz MM; Robins E
    Acta Psychiatr Scand; 1992 Apr; 85(4):270-4. PubMed ID: 1595360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI; Ryan CE; Kohn R; Miller IW; Norman WH; Brown WA
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA; Zitman FG; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Hoogendijk WJ; Smit JH; Penninx BW
    Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower serum transcortin (CBG) in major depressed females: relationships with baseline and postdexamethasone cortisol values.
    Maes M; Van Gastel A; Blockx P; Martin M; Cosyns P; Scharpé S; Ranjan R; Desnyder R
    J Affect Disord; 1996 Apr; 38(1):47-56. PubMed ID: 8735158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPA axis hyperactivity and recovery from functional psychoses.
    Coryell WH; Zimmerman M
    Am J Psychiatry; 1989 Apr; 146(4):473-7. PubMed ID: 2929747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.